Benjamin J. Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin J. Wolf has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Adam Kashishian
Gilead Sciences, Foster City, California
11 shared publications - Caroline G. Fahey
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
11 shared publications - Choudhury Fabliha B. Yusuf
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
11 shared publications - Cloud P. Paweletz
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
11 shared publications - David Allen Barbie
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
11 shared publications - David R. Liu
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
11 shared publications
Latest Publications
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS1 shows the figures related to Figure 1.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS1 shows the figures related to Figure 1.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS1 shows the figures related to Figure 1.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS1 shows the figures related to Figure 1.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S3 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS3 shows the figures related to Figure 3.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S3 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS3 shows the figures related to Figure 3.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S2 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS2 shows the figures related to Figure 2.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S2 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS2 shows the figures related to Figure 2.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S4 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS4 shows the figures related to Figure 4.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S4 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS4 shows the figures related to Figure 4.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S2 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS2 shows the figures related to Figure 2.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S2 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS2 shows the figures related to Figure 2.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Sup. Table S1 shows sequence for qRT-PCR primers and sgRNAs
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Sup. Table S1 shows sequence for qRT-PCR primers and sgRNAs
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Sup. Table S1 shows sequence for qRT-PCR primers and sgRNAs
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Sup. Table S1 shows sequence for qRT-PCR primers and sgRNAs
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S3 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS3 shows the figures related to Figure 3.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S3 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS3 shows the figures related to Figure 3.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary figure S4 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS4 shows the figures related to Figure 4.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S4 from TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Supplementary figureS4 shows the figures related to Figure 4.